3decision Verified Customer Reviews (2026)

AlisQI is a Quality Management platform built for process and batch manufacturers who want operational control without adding administrative overhead. Where many QMS platforms were designed around document storage and event tracking, AlisQI was architected as a data-first system. Quality, laboratory, and production data are structured and connected in a single operational backbone. This enables teams to see deviations earlier, understand performance trends in context, and act before issues escalate into waste, rework, or customer complaints. The platform includes modular capabilities across document control, training, deviations, CAPA, audits, risk management, supplier quality, SPC, and EHS. These capabilities are deployed through focused, ready-to-use Solvers that combine workflows, logic, dashboards, and analytics to address specific operational challenges without unnecessary scope. Because the system is built on structured, connected data, manufacturers can apply practical AI directly inside their workflows. This includes automated extraction of supplier COA data without predefined templates, conversational access to quality records, intelligent rule generation, and pattern recognition across incidents to strengthen corrective action effectiveness. Solvers are production-ready from the outset and evolve as products, processes, or sites change. Improvements do not require custom development or large IT programs, allowing organizations to modernize quality step by step. Manufacturers across chemicals, plastics, packaging, food and beverage, automotive, and industrial sectors use AlisQI to reduce firefighting, increase predictability, strengthen compliance, and turn quality data into operational intelligence.

AnalyticsCreator helps Microsoft data teams turn governed design into deployable data solutions without introducing a proprietary runtime layer. Teams use AnalyticsCreator to define warehouse structures, transformation logic, historisation rules, relationships and dependencies in a central model. From that model, the application can generate native implementation assets for technologies such as SQL Server, SSIS, Azure Data Factory, Microsoft Fabric and Power BI. The approach is designed for organisations that want to standardise how data warehouses and data products are engineered while keeping full control of the resulting code and project artefacts. Generated outputs can be integrated into existing Git, Azure DevOps and CI/CD workflows for versioning, review and controlled deployment across environments. AnalyticsCreator supports dimensional, 3NF and hybrid modelling as well as common engineering patterns including delta loading, Slowly Changing Dimensions, snapshots and historisation. Documentation, lineage and dependency information are maintained alongside the project design, making it easier to assess the impact of proposed changes and keep implementation aligned with the underlying model. The AnalyticsCreator Governed Control Model provides the foundation for this process by keeping business meaning, technical structures and implementation logic connected. Design Intelligence builds on that context by making governed project metadata, lineage, dependencies and design rules available to authorised AI tools and agents. Typical use cases include modernising SQL Server and SSIS estates, building Microsoft Fabric solutions, standardising Power BI delivery and creating repeatable data warehouse and data product engineering processes.

Site-Identification by Ligand Competitive Saturation (SILCS) generates three-dimensional representations called FragMaps, which depict the interactions of various chemical functional groups with a designated target molecule. By uncovering the intricacies of molecular dynamics, SILCS provides essential tools that facilitate the refinement of ligand scaffolds, offering both qualitative and quantitative perspectives on binding sites, which ultimately aids in optimizing the drug design workflow. This methodology utilizes a selection of small molecule probes, each possessing a variety of functional groups, along with explicit solvent modeling and the flexibility of the target molecule to effectively map protein targets. Moreover, the technique empowers researchers to visualize beneficial interactions with the target macromolecule, allowing for a more informed design process. Armed with these insights, scientists can strategically engineer enhanced ligands with functional groups positioned for maximum efficacy. The pioneering approach of SILCS marks a noteworthy leap forward in the realm of medicinal chemistry, opening new avenues for drug discovery and development. Through its advanced analytical capabilities, SILCS not only enhances understanding but also drives innovation in therapeutic design.